148 related articles for article (PubMed ID: 22042094)
21. Parathyroid hormone-related peptide (PTHrP), parathyroid hormone/parathyroid hormone-related peptide receptor 1 (PTHR1), and MSX1 protein are expressed in central and peripheral giant cell granulomas of the jaws.
Houpis CH; Tosios KI; Papavasileiou D; Christopoulos PG; Koutlas IG; Sklavounou A; Alexandridis C
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2010 Mar; 109(3):415-24. PubMed ID: 20060342
[TBL] [Abstract][Full Text] [Related]
22. Cytomorphometric and immunohistochemical comparison between central and peripheral giant cell lesions of the jaws.
Flórez-Moreno GA; Henao-Ruiz M; Santa-Sáenz DM; Castañeda-Peláez DA; Tobón-Arroyave SI
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2008 May; 105(5):625-32. PubMed ID: 18299236
[TBL] [Abstract][Full Text] [Related]
23. Novel mutations in the SH3BP2 gene associated with sporadic central giant cell lesions and cherubism.
Carvalho VM; Perdigão PF; Amaral FR; de Souza PE; De Marco L; Gomez RS
Oral Dis; 2009 Jan; 15(1):106-10. PubMed ID: 19017279
[TBL] [Abstract][Full Text] [Related]
24. Intralesional injection of triamcinolone hexacetonide as an alternative treatment for central giant cell lesions: a prospective study.
Nogueira RLM; Osterne RLV; Lima Verde RMB; Azevedo NO; Teixeira RC; Cavalcante RB
Br J Oral Maxillofac Surg; 2020 Dec; 58(10):e283-e289. PubMed ID: 32792199
[TBL] [Abstract][Full Text] [Related]
25. Giant cell lesions of the jaws: does the level of vascularity and angiogenesis correlate with behavior?
Peacock ZS; Jordan RC; Schmidt BL
J Oral Maxillofac Surg; 2012 Aug; 70(8):1860-6. PubMed ID: 22104131
[TBL] [Abstract][Full Text] [Related]
26. [Central giant cell lesions of the jaws: a clinicopathological study of 31 cases].
Liu B; Yu SF; Wu YT; Pang SZ
Zhonghua Kou Qiang Yi Xue Za Zhi; 2005 Jan; 40(1):67-9. PubMed ID: 15774157
[TBL] [Abstract][Full Text] [Related]
27. Are CD68 and Factor VIII-RA Expression Different in Central and Peripheral Giant Cell Granuloma of Jaw: An Immunohistochemical Comparative Study.
Sargolzaei S; Taghavi N; Poursafar F
Turk Patoloji Derg; 2017; 1(1):49-56. PubMed ID: 28832079
[TBL] [Abstract][Full Text] [Related]
28. Multinucleated giant cells in various forms of giant cell containing lesions of the jaws express features of osteoclasts.
Liu B; Yu SF; Li TJ
J Oral Pathol Med; 2003 Jul; 32(6):367-75. PubMed ID: 12787044
[TBL] [Abstract][Full Text] [Related]
29. Increased expression of NFATc1 in giant cell lesions of the jaws, cherubism and brown tumor of hyperparathyroidism.
Duarte AP; Gomes CC; Gomez RS; Amaral FR
Oncol Lett; 2011 May; 2(3):571-573. PubMed ID: 22866121
[TBL] [Abstract][Full Text] [Related]
30. Pharmacological Therapy for Treatment of Recurrent Central Giant Cell Lesion in a Child.
Fernandes Gonçalves IM; Barbosa Luna AH; de Melo DP; Weege Nonaka CF; Alves PM
J Dent Child (Chic); 2019 May; 86(2):113-117. PubMed ID: 31395117
[TBL] [Abstract][Full Text] [Related]
31. Fine needle aspiration biopsy in central giant cell lesion: a report of 3 cases.
Vargas PA; Prado FO; Fregnani ER; Perez DE; Lopes MA; de Moraes M; Gerhard R
Acta Cytol; 2006; 50(4):449-54. PubMed ID: 16901013
[TBL] [Abstract][Full Text] [Related]
32. Hybrid Central Odontogenic Fibroma with Giant Cell Granuloma like Lesion: A Report of Three Additional Cases and Review of the Literature.
Upadhyaya JD; Cohen DM; Islam MN; Bhattacharyya I
Head Neck Pathol; 2018 Jun; 12(2):166-174. PubMed ID: 28785965
[TBL] [Abstract][Full Text] [Related]
33. Central giant cell lesion: diagnosis to rehabilitation.
Pellicioli AC; Kaefer T; Martins MA; Carrard VC; Martins MD
Gen Dent; 2015; 63(1):e16-9. PubMed ID: 25574728
[TBL] [Abstract][Full Text] [Related]
34. Immunoexpression of MMP-9, VEGF, and vWF in central and peripheral giant cell lesions of the jaws.
Matos FR; Nonaka CF; Miguel MC; Galvão HC; de Souza LB; Freitas Rde A
J Oral Pathol Med; 2011 Apr; 40(4):338-44. PubMed ID: 21198871
[TBL] [Abstract][Full Text] [Related]
35. [Central reparative giant cell granuloma of the jaw. Morphological study].
Chomette G; Auriol M; Labrousse F; Guilbert F
Rev Stomatol Chir Maxillofac; 1989; 90(2):131-5. PubMed ID: 2727610
[TBL] [Abstract][Full Text] [Related]
36. Angiogenesis pattern and H3.3 histone mutation in aggressive and non-aggressive central giant cell lesions.
de Oliveira Filho SA; Martins AFL; Mosconi C; de Paula HM; Mendonça EF
Arch Oral Biol; 2021 Oct; 130():105218. PubMed ID: 34364170
[TBL] [Abstract][Full Text] [Related]
37. [Expression of receptor activator of NF-kappa B ligand and osteoprotegerin protein in the giant cell lesions of jaw].
Meng XM; Yu SF; Wei MJ
Zhonghua Kou Qiang Yi Xue Za Zhi; 2005 Jul; 40(4):294-7. PubMed ID: 16191370
[TBL] [Abstract][Full Text] [Related]
38. Comprehensive Genomic Profiling of Central Giant Cell Lesions Identifies Clinically Relevant Genomic Alterations.
Bezak B; Lehrke H; Elvin J; Gay L; Schembri-Wismayer D; Viozzi C
J Oral Maxillofac Surg; 2017 May; 75(5):955-961. PubMed ID: 27883876
[TBL] [Abstract][Full Text] [Related]
39. Involvement of mast cells and microvessels density in reactive lesions of oral cavity: A comparative immunohistochemical study.
Ferreira SV; Xavier FC; Freitas Mda C; Nunes FD; Gurgel CA; Cangussu MC; Martins MD; Freitas VS; Dos Santos JN
Pathol Res Pract; 2016 Sep; 212(9):761-6. PubMed ID: 27493102
[TBL] [Abstract][Full Text] [Related]
40. Prognostic significance of cortical perforation in the recurrence of central giant cell granulomas of the jaws.
Minić A; Stajcić Z
J Craniomaxillofac Surg; 1996 Apr; 24(2):104-8. PubMed ID: 8773892
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
